You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 2, February 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Renal Diseases
 •Dialysis
 •Dermatologic Disorders, Other
 •Dermatology, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

VIGNETTES
Calciphylaxis Responding to Sodium Thiosulfate Therapy

Brian L. Baker, MD; Carrie A. Fitzgibbons, BS; Lucinda S. Buescher, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Calciphylaxis is an uncommon and extremely painful calcifying panniculitis, most often seen in patients with end-stage renal disease. The prognosis is poor, with a 6-month mortality rate ranging from 33% to 80%.1 Dermatologists are often called on to diagnose the condition, but unfortunately, successful treatments have not been available. We describe a case that responded to treatment with sodium thiosulfate.

Report of a Case

A 68-year-old obese African American woman with a medical history of type 2 diabetes mellitus, hypercholesterolemia, hypertension, coronary artery disease, and congestive heart failure presented with a 1-month history of extremely painful, indurated, depressed plaques with necrotic ulceration and eschar on her outer thighs bilaterally (Figure 1). At that time, her home medications included pioglitazone, aspirin, furosemide, metolazone, amitriptyline, insulin, ranitidine, fosinopril, levothyroxine, atorvastatin, clopidogrel, and carvedilol. Analysis of an incisional biopsy specimen showed areas of . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION

RELATED LETTERS

Sodium Thiosulfate as First-Line Treatment for Calciphylaxis
Felix Ackermann, Annabelle Levy, Eric Daugas, Noel Schartz, Anne Riaux, Christian Derancourt, Pablo Urena, and Celeste Lebbé
Arch Dermatol. 2007;143(10):1336-1337.
EXTRACT | FULL TEXT  

Sodium Thiosulfate as First-Line Treatment for Calciphylaxis—Reply
Maria R. Robinson, Joshua J. Augustine, and Neil J. Korman
Arch Dermatol. 2007;143(10):1338.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Cinacalcet for the Treatment of Calciphylaxis
Maria R. Robinson, Joshua J. Augustine, and Neil J. Korman
Arch Dermatol. 2007;143(2):152-154.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sodium Thiosulfate as First-Line Treatment for Calciphylaxis
Ackermann et al.
Arch Dermatol 2007;143:1336-1337.
FULL TEXT  

Sodium Thiosulfate as First-Line Treatment for Calciphylaxis Reply
Robinson et al.
Arch Dermatol 2007;143:1338-1338.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.